Brimonidine Tartrate Ophthalmic Solution, 0.1%

Somerset Therapeutics

Revision date : 2024-08-06

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

1303-96-4

Name of the chemical

Disodium tetraborate, anhydrous

Concentration

N/A

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

EC/CAS

7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

N/A

General Information

Revision date

2024-08-06

Product name

Brimonidine Tartrate Ophthalmic Solution, 0.1%

Product Synonyms

Brimonidine Tartrate Ophthalmic drops

1.2.1 Relevant identified uses

Alpha-Adrenergic Receptor Intra-ocular Pressure (IOP

Icons in SDS

M004 M009 M010 M059

Company Information

company name

Somerset Therapeutics

Section 2

SECTION 2: Hazards identification

OSHA Hazards Classification

2.2 Label elements

Emergency Overview The product contains no substances which at their given concentration, are considered to be hazardous to health Appearance Liquid Physical state Liquid Odor Slight Chemical Name Potassium Chloride Symptoms The most common adverse reactions to potassium chloride are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarhhea. One the most severe adverse side effects is hyperkalemia, There have also been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation. Brimonidine tartrate Prolonged or repeated exposure can cause central nervous system effects. allergic conjunctivitis, burning sensation, conjunctival folliculosis, conjunctival hyperemia, eye pruritus, hypertension, ocular allergic reaction, oral dryness, and visual disturbance. Chemical Name Potassium Chloride

Medical Conditions Generally Aggravated by Exposure

Contraindications occur in patients with hyperkalemia since a further increase in serum potassium concentration in such patients can produce cardiac arrest. Hyperkalemia may complicate the following conditions: chronic renal failure, systemic acidosis, acute dehydration, extensive tissue beak down and adrenal insufficiency. Other contraindications occur in any patient in whom there is structural, pathological or pharmacologic cause for arrest or delay in tablet passage Brimonidine tartrate through the gastrointestinal tract. Antihypertensives/cardiac glycosides may lower blood pressure. Use with CNS depressants may result in an additive or potentiating effect. Tricyclic antidepressants may potentially blunt the hypotensive effect of systemic clonidine. Monoamine oxidase inhibitors may result in increased hypotension.

Further information

Unknown Acute Toxicity 99.9% of the mixture consists of ingredient(s) of unknown toxicity

2.1 Classification of the substance or mixture

OSHA Regulatory Status This chemical is not considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.122) Not a dangerous substance or mixture according to the Globally Harmonized System (GHS)

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.